Skip to main content

Table 2 CDCA8 expression correlated with clinical pathological characteristics (logistic regression)

From: CDCA8 as an independent predictor for a poor prognosis in liver cancer

Clinical characteristics Total (N) Odds ratio in CDCA8 expression P-value
T stage (T1/2 vs. T3/4 ) 415 1.64 (1.03–2.62) 0.035
N stage (N0 vs. N1 ) 298 3.11 (0.70-21.48) 0.169
M stage (M0 vs. M1 ) 311 0.74 (0.14–3.44) 0.703
Clinical stage (I/II vs. III/IV) 394 1.66 (1.04–2.67) 0.034
Age (≤ 61 vs.> 61) 376 1.30 (0.86–1.95) 0.212
Gender (Female vs. Male) 418 0.70 (0.47–1.06) 0.095
Histologic grade (G1 vs.G4) 68 6.71 (1.76–33.18) 0.009
Histological type (CHOL vs. LIHC) 418 0.24 (0.10–0.54) 0.001
Race (Not white vs. White) 408 0.88 (0.594–1.31) 0.544
  1. Categorical dependent variable, greater or less than the median expression level. Italic represents P‑values < 0.005. LIHC, Liver hepatocellular carcinoma; CHOL, Cholangiocarcinoma; T, topography distribution; N, lymph node metastasis; M, distant metastasis